
About Lyfegen
Lyfegen is a Technology company based in Basel (Switzerland) founded in 2018. Provider of pricing model databases for drugs and medical devices. Lyfegen has raised $16.64 million across 4 funding rounds from investors including TX Ventures, aMoon and APEX Ventures. Lyfegen offers products and services including Lyfegen Platform. Its focus areas include Enterprise Applications, Data as a Service, Industries and Healthcare Data.
Company details
Lyfegen was founded in 2018 in Basel, Switzerland, within the healthcare sector. Databases containing pricing models for drugs and medical devices are maintained, enabling payers to monitor patient treatments and allocate funds. Access to public agreements, contracts, and drug pricing information is offered to regulators, pharmaceutical companies, and payers. Real-time tracking of financial performance is also facilitated through the platform.
- Headquarters Basel, Switzerland
- SectorsTechnology
- Emailβ’β’β’β’β’β’β’β’
- Website lyfegen.com
- Social LinkedIn X
- Total Equity Funding$16.64M (USD)
in 4 rounds
- Latest Funding Round$5.68M (USD), Series A
Dec 2024
- InvestorsTX Ventures
& 2 more
Products & Services of Lyfegen
Lyfegen offers a comprehensive portfolio of products and services, including Lyfegen Platform.
Platform for exploring and connecting pharma payers and providers.
Funding Insights of Lyfegen
Lyfegen has successfully raised a total of $16.64M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $5.68 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.64M
- Total Rounds 4
- Last Round Series A β $5.68M
- First Round $745,625
(Apr 2019)
- Investors Count 3
All 4 funding rounds of Lyfegen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2024 | $5.68M | Series A | β | TX Ventures | |
| Sep 2022 | $8M | Series A | β | aMoon | |
| Sep 2020 | $2.21M | Series A | β | β | β |
| Apr 2019 | $745,625 | Seed | β | β | β |
3 investors in total: 3 institutional.
Investors in Lyfegen
Lyfegen has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include TX Ventures, aMoon and APEX Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made in Fintech and related sectors by TX Ventures. | tx.ventures | Zurich, Switzerland | ||
Venture capital investments in healthcare are focused on by aMoon. | amoon.fund | |||
Venture capital funding is offered for deep-tech and medical startups. | apex.ventures | Vienna, Austria |
Investor details for Lyfegen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Lyfegen
3 dated milestones of Lyfegen across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Lyfegen is founded.
- Funding First funding round of $746K.
- Funding Latest funding round, Series A, of $5.7M.
Web traffic of Lyfegen
The website of Lyfegen (lyfegen.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▲ 108.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lyfegen
Complete news archive for Lyfegen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lyfegen
Lyfegen was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Lyfegen is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Lyfegen is a funded company, having raised a total of $16.64M across 4 funding rounds to date. The company's 1st funding round was a Seed of $745.63K, raised on Apr 2019.
Lyfegen was founded in 2018 in Basel, Switzerland, within the healthcare sector. Databases containing pricing models for drugs and medical devices are maintained, enabling payers to monitor patient treatments and allocate funds. Access to public agreements, contracts, and drug pricing information is offered to regulators, pharmaceutical companies, and payers. Real-time tracking of financial performance is also facilitated through the platform.
Lyfegen offers Lyfegen Platform.
Lyfegen has 3 investors. Key investors include TX Ventures, aMoon, and APEX Ventures.
